CureMD and Greenway Intergy both describe themselves as unified EHR and practice management platforms, but their public documentation emphasizes different operational priorities. CureMD's materials foreground AI-assisted documentation, specialty templates, and a bundled billing service, while Greenway's developer documentation concentrates on FHIR access, opt-in procedures, and the Intergy Suite's specialty-focused workflows. A buyer comparing the two should treat marketing pages and technical documentation as separate evidence types. The technical documents reveal concrete integration mechanics, while the product pages state capabilities that require validation against a practice's actual configuration. This comparison organizes the documented differences around interoperability, charting and AI features, practice management scope, and implementation requirements, without assigning a winner where the sources do not support one.

Interoperability: Different FHIR Maturity and Access Paths

CureMD's FHIR API documentation states that the company has implemented the HL7 FHIR standard to support the ONC (g)(10) certification criterion for standardized patient and population services [1]. The document describes an OAuth 2.0 authorization code flow with options for asymmetric JWKS authentication or a client secret, and it includes a public EHR launch flow for provider-facing single-page and mobile applications [1]. The registration process requires developers to submit application details, SMART scopes, supported operating systems, and privacy or security attestations to CureMD support [1]. The document's table of contents lists FHIR resources including Medication Dispense, Specimen, Service Request, and Appointment, but the retrieved passages do not state whether write operations are supported [1].

Greenway's developer documentation describes two distinct APIs for Intergy and Prime Suite: a standards-based FHIR R4 API and a proprietary Greenway API, or GAPI [9]. The FHIR API currently supports read operations only, according to the overview document [9]. The GAPI supports reads and writes across clinical and financial data elements, but the documentation does not list those elements in the retrieved passages [9]. Greenway's FHIR reference lists resources including AllergyIntolerance, CarePlan, Condition, Encounter, MedicationRequest, Observation, Patient, and Procedure, among others [11]. A buyer evaluating interoperability should confirm which resources each vendor exposes in production and whether the read-only limitation on Greenway's FHIR API affects planned integrations.

AI-Assisted Charting: CureMD's Embedded Claims vs. Greenway's Silence

CureMD's product pages describe an ambient AI medical scribe that listens to patient conversations and produces structured SOAP notes with suggested ICD-10 and E/M codes [3][4]. The vendor states that the scribe supports English, Spanish, and twelve additional languages, and that it works on a phone [4]. CureMD also claims predictive clinical insights for risk scores, drug interactions, and missing labs, along with coding gap detection that the vendor says can boost revenue capture by up to 12 percent [4]. These are vendor claims about product capabilities, not independently verified outcomes. The documentation does not provide a technical specification for how the scribe handles specialty-specific terminology or how suggested codes are validated before sign-off.

Greenway's retrieved documentation does not describe an ambient AI scribe or AI-generated clinical notes for Intergy. The Intergy Suite brochure emphasizes specialty-focused features, customizable workflows, and integration between EHR and practice management, but it does not mention AI-assisted documentation [12]. Greenway's developer materials focus on API access and FHIR resources rather than clinical AI features [9][10][11]. This absence does not prove that Intergy lacks AI capabilities; it means the retrieved sources do not document them. A buyer for whom ambient documentation is a priority should request a Greenway demonstration or specification sheet, while a buyer evaluating CureMD should ask for evidence that the AI scribe performs as described in their specialty.

A Suggested Evaluation Workflow for This Pair

A practice evaluating CureMD and Intergy could structure a two-week review around documented decision points. First, request a FHIR capability statement from both vendors and compare the resource lists against the integrations the practice actually uses. Greenway's reference documentation lists specific FHIR resources and states that its FHIR API is read-only, so ask Greenway whether the proprietary GAPI covers any required write operations [9][11]. For CureMD, request the same resource list and confirm whether write operations are supported, since the retrieved FHIR documentation does not state this [1]. Second, schedule a specialty-specific demonstration of CureMD's AI scribe and ask for a sample note from a comparable specialty, while asking Greenway to demonstrate its current documentation workflow for the same encounter type [3][12]. Third, request implementation timelines and data migration plans from both vendors, noting that Greenway documents a 15-day average FHIR activation window but CureMD does not publish an equivalent figure [3][10].

Practice Management and Billing: Bundled Services vs. Suite Architecture

CureMD markets a unified platform that includes EHR, practice management, patient engagement, and medical billing services [2]. The vendor's practice management page lists personalized dashboards, enterprise scheduling, real-time eligibility verification, claim scrubbing, denial management, and payer management [2]. CureMD also describes a medical billing service with dedicated teams, A/R aging reports, and reimbursement tracking by carrier [2]. The vendor states a 98 percent clean claim rate and a 99 percent customer retention figure on its marketing page, but these are self-reported metrics without a defined denominator or audit methodology in the retrieved source [2]. Buyers should treat these figures as vendor claims requiring verification.

Greenway's Intergy Suite brochure describes a combined EHR and advanced practice management solution with specialty-focused features and customizable workflows [12]. The brochure does not enumerate specific billing metrics or a separate medical billing service in the retrieved passages. Greenway's developer documentation indicates that the proprietary GAPI supports reads and writes across clinical and financial data elements, which suggests financial data access is part of the platform's integration surface [9]. The difference in documentation emphasis means a buyer comparing billing capabilities must request a feature-level comparison from both vendors, because the public sources do not provide equivalent detail.

Implementation and FHIR Onboarding: Different Activation Requirements

CureMD's EMR page states that implementation and training are included with a flat monthly subscription, and that a dedicated team remains assigned to the practice with ongoing support [3]. The vendor also claims that switching is a process it has refined, but the retrieved passage does not specify a timeline or data migration methodology [3]. CureMD's FHIR documentation describes a client registration process that requires emailing application details to support, after which the support team shares credentials [1]. This suggests a manual registration step for third-party developers, but the source does not state how long registration takes.

Greenway's FHIR onboarding documentation is more explicit about activation steps. Practices must opt into FHIR services through a form on records.greenwayhealth.com, using MyGreenway login credentials [10]. The documentation states that Intergy sites must provide their Site ID, which is the Intergy License number [10]. Greenway advises permitting up to 15 days on average for FHIR activation, with large practices potentially taking longer [10]. The system must be on a minimum version that changes annually, and practices below that version must update before onboarding [10]. This level of procedural detail is absent from CureMD's retrieved FHIR documentation, which may matter to a buyer planning third-party integrations.

Specialty Coverage and Platform Claims

CureMD states that its EMR ships clinical content, order sets, and coding patterns for more than 30 specialties [3]. One page says the ambient AI scribe is live in all 32 specialties, while another references 30 or more specialties [3][4]. The vendor also claims trust from 50,000 or 40,000 providers across the U.S. on different pages, a discrepancy that reflects inconsistent marketing copy rather than a verified customer count [4][8]. CureMD lists awards from KLAS, Black Book, Surescripts, and Medical Economics, but the retrieved pages do not provide award years or methodology for most of these recognitions [2].

Greenway's Intergy Suite brochure describes specialty-focused features and customizable workflows without specifying a specialty count [12]. The brochure positions Intergy as a unified solution for modern healthcare practices and mentions related resources for tribal and urban Indian health centers and federally qualified health centers [12]. These references suggest Greenway markets Intergy to specific organizational settings, but the retrieved passages do not provide a specialty list or customer count. A buyer comparing specialty fit should request a specialty-specific demonstration from both vendors, because the public documentation does not provide equivalent specialty coverage data.